Literature DB >> 11754905

Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy.

Y Murakami1, T Kanamoto, T Tuboi, T Maeda, Y Inoue.   

Abstract

PURPOSE: To evaluate extraocular muscle enlargement (EME) in dysthyroid ophthalmopathy.
METHODS: EME was assessed by orbital computed tomography (CT) in 573 patients with dysthyroid ophthalmopathy in order to investigate the frequency and exact location of EME and the clinical features of related ocular symptoms in patients with dysthyroid ophthalmopathy.
RESULTS: Of the 573 patients examined, 187 patients (38%) showed evidence of EME on CT images. This disorder was more frequent in male patients than in female patients. EME was also more frequently seen in older patients than in younger patients. Enlargement of a single muscle was found in 55% of the 187 patients, with the most frequently affected muscle being the inferior rectus muscle. When multiple muscles were enlarged, the inferior rectus muscle was the most frequently affected, followed by the medial rectus muscle.
CONCLUSIONS: Of the clinical findings specific to dysthyroid ophthalmopathy examined in the present study, the incidence of exophthalmos, upper lid swelling, superior limbic keratoconjunctivitis, keratitis, diplopia, and dysthyroid optic neuropathy was significantly increased in patients with dysthyroid ophthalmopathy, indicating a close relationship between these findings and the underlying disease, but the incidence of upper lid retraction was not significantly increased.

Entities:  

Mesh:

Year:  2001        PMID: 11754905     DOI: 10.1016/s0021-5155(01)00407-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland.

Authors:  Hartmann Kainz; Reto Bale; Eveline Donnemiller; Michael Gabriel; Peter Kovacs; Clemens Decristoforo; Roy Moncayo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-13       Impact factor: 9.236

2.  Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.

Authors:  Tomoaki Higashiyama; Maki Iwasa; Masahito Ohji
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

3.  Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy.

Authors:  Tomoaki Higashiyama; Masahito Ohji
Journal:  Clin Ophthalmol       Date:  2018-11-27

4.  Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.

Authors:  Nami Suzuki; Jaeduk Yoshimura Noh; Toshiaki Kameda; Ai Yoshihara; Hidemi Ohye; Miho Suzuki; Masako Matsumoto; Yo Kunii; Kenji Iwaku; Natsuko Watanabe; Koji Mukasa; Ai Kozaki; Toshu Inoue; Kiminori Sugino; Koichi Ito
Journal:  Clin Ophthalmol       Date:  2018-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.